Autobio Diagnostics Co Ltd (603658) - Total Liabilities
Based on the latest financial reports, Autobio Diagnostics Co Ltd (603658) has total liabilities worth CN¥2.99 Billion CNY (≈ $437.09 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Autobio Diagnostics Co Ltd to evaluate the company's liquid asset resilience ratio.
Autobio Diagnostics Co Ltd - Total Liabilities Trend (2011–2025)
This chart illustrates how Autobio Diagnostics Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Autobio Diagnostics Co Ltd balance sheet assets.
Autobio Diagnostics Co Ltd Competitors by Total Liabilities
The table below lists competitors of Autobio Diagnostics Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Himadri Speciality Chemical Limited
NSE:HSCL
|
India | Rs-47.62 Billion |
|
Immunome Inc
NASDAQ:IMNM
|
USA | $40.30 Million |
|
California Water Service Group
NYSE:CWT
|
USA | $4.14 Billion |
|
Vapores
SN:VAPORES
|
Chile | CL$62.81 Million |
|
Foxconn Technology Co Ltd
TW:2354
|
Taiwan | NT$64.84 Billion |
|
Solusi Tunas Pratama Tbk
JK:SUPR
|
Indonesia | Rp2.40 Trillion |
|
Manappuram Finance Limited
NSE:MANAPPURAM
|
India | Rs389.37 Billion |
|
Allied Gold Corporation
TO:AAUC
|
Canada | CA$1.26 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Autobio Diagnostics Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Autobio Diagnostics Co Ltd (603658) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.67 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Autobio Diagnostics Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Autobio Diagnostics Co Ltd (2011–2025)
The table below shows the annual total liabilities of Autobio Diagnostics Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥3.27 Billion ≈ $479.01 Million |
+2.83% |
| 2024-12-31 | CN¥3.18 Billion ≈ $465.81 Million |
+10.23% |
| 2023-12-31 | CN¥2.89 Billion ≈ $422.57 Million |
+12.80% |
| 2022-12-31 | CN¥2.56 Billion ≈ $374.63 Million |
+39.94% |
| 2021-12-31 | CN¥1.83 Billion ≈ $267.71 Million |
+17.89% |
| 2020-12-31 | CN¥1.55 Billion ≈ $227.08 Million |
-4.34% |
| 2019-12-31 | CN¥1.62 Billion ≈ $237.39 Million |
+134.88% |
| 2018-12-31 | CN¥690.69 Million ≈ $101.07 Million |
+38.74% |
| 2017-12-31 | CN¥497.85 Million ≈ $72.85 Million |
+182.04% |
| 2016-12-31 | CN¥176.52 Million ≈ $25.83 Million |
-22.24% |
| 2015-12-31 | CN¥227.01 Million ≈ $33.22 Million |
+50.26% |
| 2014-12-31 | CN¥151.08 Million ≈ $22.11 Million |
+115.85% |
| 2013-12-31 | CN¥70.00 Million ≈ $10.24 Million |
+50.82% |
| 2012-12-31 | CN¥46.41 Million ≈ $6.79 Million |
+17.92% |
| 2011-12-31 | CN¥39.36 Million ≈ $5.76 Million |
-- |
About Autobio Diagnostics Co Ltd
Autobio Diagnostics Co., Ltd. engages in the research and development, production, marketing, sale, and service of clinical diagnostic products in China and internationally. The company offers immunoassay, biochemistry, and microbiology products; reagents and instruments; and technical and support, and training services, as well as engages in biology research and development activities. Its immun… Read more